These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 29621096)

  • 1. PTEN Expression in Mucinous Prostatic Adenocarcinoma, Prostatic Adenocarcinoma With Mucinous Features, and Adjacent Conventional Prostatic Adenocarcinoma: A Multi-institutional Study of 92 Cases.
    Bertsch EC; Magi-Galluzzi C; Cheng L; Osunkoya AO
    Appl Immunohistochem Mol Morphol; 2018 Apr; 26(4):225-230. PubMed ID: 29621096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ERG expression in mucinous prostatic adenocarcinoma and prostatic adenocarcinoma with mucinous features: comparison with conventional prostatic adenocarcinoma.
    Johnson H; Zhou M; Osunkoya AO
    Hum Pathol; 2013 Oct; 44(10):2241-6. PubMed ID: 23849895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MUC2 expression in primary mucinous and nonmucinous adenocarcinoma of the prostate: an analysis of 50 cases on radical prostatectomy.
    Osunkoya AO; Adsay NV; Cohen C; Epstein JI; Smith SL
    Mod Pathol; 2008 Jul; 21(7):789-94. PubMed ID: 18487999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of ERG and PTEN protein expression in cribriform architecture prostate carcinomas.
    Downes MR; Satturwar S; Trudel D; van der Kwast TH
    Pathol Res Pract; 2017 Jan; 213(1):34-38. PubMed ID: 27913052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary mucin-producing urothelial-type adenocarcinoma of prostate: report of 15 cases.
    Osunkoya AO; Epstein JI
    Am J Surg Pathol; 2007 Sep; 31(9):1323-9. PubMed ID: 17721186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histochemical and immunohistochemical evidence of tumor heterogeneity in colorectal cancer.
    Zlatian OM; Comănescu MV; Roşu AF; Roşu L; Cruce M; Găman AE; Călina CD; Sfredel V
    Rom J Morphol Embryol; 2015; 56(1):175-81. PubMed ID: 25826503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of mammalian target of rapamycin signaling pathway markers in minute adenocarcinoma of the prostate.
    Faraj SF; Albadine R; Chaux A; Gonzalez-Roibon N; Hicks J; Humphreys E; Partin A; Netto GJ
    Urology; 2013 Nov; 82(5):1083-9. PubMed ID: 24035134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucin-producing tumors and tumor-like lesions involving the prostate: a comprehensive review.
    Bohman KD; Osunkoya AO
    Adv Anat Pathol; 2012 Nov; 19(6):374-87. PubMed ID: 23060063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of ERG and Wild-Type PTEN Are Associated with Favorable Clinical Prognosis and Low Biochemical Recurrence in Prostate Cancer.
    Kim SH; Kim SH; Joung JY; Lee GK; Hong EK; Kang KM; Yu A; Nam BH; Chung J; Seo HK; Park WS; Lee KH
    PLoS One; 2015; 10(4):e0122498. PubMed ID: 25897494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucin production in prostatic adenocarcinoma: a retrospective study of 190 radical prostatectomy and/ or core biopsy specimens in department of pathology, Siriraj Hospital, Mahidol University, Thailand.
    Noiwan S; Rattanarapee S
    J Med Assoc Thai; 2011 Feb; 94(2):224-30. PubMed ID: 21534370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucinous adenocarcinoma of prostate and prostatic adenocarcinoma with mucinous components: a clinicopathological analysis of 143 cases.
    Samaratunga H; Delahunt B; Srigley JR; Yaxley J; Johannsen S; Coughlin G; Gianduzzo T; Kua B; Patterson I; Nacey JN; Egevad L
    Histopathology; 2017 Oct; 71(4):641-647. PubMed ID: 28590015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucinous and secondary tumors of the prostate.
    Osunkoya AO
    Mod Pathol; 2018 Jan; 31(S1):S80-S95. PubMed ID: 29297488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTEN loss and ERG protein expression are infrequent in prostatic ductal adenocarcinomas and concurrent acinar carcinomas.
    Morais CL; Herawi M; Toubaji A; Albadine R; Hicks J; Netto GJ; De Marzo AM; Epstein JI; Lotan TL
    Prostate; 2015 Oct; 75(14):1610-9. PubMed ID: 26178158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implication of miRNA-153 on PTEN expression in prostatic adenocarcinoma.
    Aboushousha T; El-Nahas EI; El-Hindawi A; Elwi D; El-Ganzouri H; Hammam O; Magdy M; Helal NS
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):6834-6843. PubMed ID: 34859846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucinous adenocarcinoma of the prostate: histochemical and immunohistochemical studies.
    Ro JY; Grignon DJ; Ayala AG; Fernandez PL; Ordonez NG; Wishnow KI
    Hum Pathol; 1990 Jun; 21(6):593-600. PubMed ID: 1693591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucinous carcinomas of the gallbladder: clinicopathologic analysis of 15 cases identified in 606 carcinomas.
    Dursun N; Escalona OT; Roa JC; Basturk O; Bagci P; Cakir A; Cheng J; Sarmiento J; Losada H; Kong SY; Ducato L; Goodman M; Adsay NV
    Arch Pathol Lab Med; 2012 Nov; 136(11):1347-58. PubMed ID: 23106580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expressions of FHIT and PTEN and their significance in prostate cancer].
    Xiao Q; Gu XW; Jiang JX; Wang CM; Xu Q
    Zhonghua Nan Ke Xue; 2011 Feb; 17(2):136-9. PubMed ID: 21404710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTEN expression and morphological patterns in prostatic adenocarcinoma.
    Spieker AJ; Gordetsky JB; Maris AS; Dehan LM; Denney JE; Arnold Egloff SA; Scarpato K; Barocas DA; Giannico GA
    Histopathology; 2021 Dec; 79(6):1061-1071. PubMed ID: 34324714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoexpression and clinical significance of the PTEN and MLH1 proteins in endometrial carcinomas.
    Bąkiewicz A; Michalak J; Sporny S
    Pol J Pathol; 2010; 61(4):185-91. PubMed ID: 21290340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mucinous adenocarcinoma of the prostate: a case report and review of 32 cases on immunohistochemical study of both PSA and CEA].
    Furuta A; Naruoka T; Hasegawa N; Suzuki Y; Ikemoto I; Oishi Y
    Nihon Hinyokika Gakkai Zasshi; 2003 Jul; 94(5):570-3. PubMed ID: 12910933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.